Boothbay Fund Management’s AstraZeneca AZN Stock Holding History

Boothbay Fund Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-34,950	Closed	-$4.73M	–	1649
2023 Q3	$4.73M	Sell	34,950 -338,750	-91%	-$46.3M	0.11%	230
2023 Q2	$53.5M	Buy	373,700 +302,350	+424%	+$44.5M	1.17%	4
2023 Q1	$9.9M	Buy	+71,350	New	+$9.6M	0.2%	79
2017 Q3	–	Sell	-21,250	Closed	-$1.45M	–	605
2017 Q2	$1.45M	Buy	+21,250	New	+$1.39M	0.3%	65

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Boothbay Fund Management's AZN Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in AstraZeneca (AZN) in Q1 2026: 3,867 shares worth $763K. The stake represents 0.01% of the portfolio and ranks #1099 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in AZN as recently as Q3 2025.

Boothbay Fund Management first reported a position in AZN in Q3 2019 and has held it in 17 quarters since. The position peaked at $10.2M in Q1 2021. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Boothbay Fund Management held 3,867 shares of AstraZeneca worth $763K as of Q1 2026.
AstraZeneca was a new Boothbay Fund Management position in Q1 2026.
AstraZeneca made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1099 holding.
Boothbay Fund Management first reported a position in AstraZeneca in Q3 2019 and has held it in 17 quarters since.
Boothbay Fund Management's AstraZeneca position peaked at $10.2M in Q1 2021.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.